Molecular characterization of neoplastic and normal “sister” lymphoblastoid B-cell lines from chronic lymphocytic leukemia

References

• Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804–815.
   PubMed Web of Science ®Google Scholar
• Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20 + CD27+ CD43 + CD70. J Exp Med 2011;208:67–80.
   PubMed Web of Science ®Google Scholar
• Rosén A, Bergh A-C, Gogolák P, et al. Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection. OncoImmunology 2012;1: 18–27.
   PubMed Web of Science ®Google Scholar
• Chiorazzi N, Ferrarini M. Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 2011;117:1781–1791.
   PubMed Web of Science ®Google Scholar
• Seifert M, Sellmann L, Bloehdorn J, et al. Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med 2012; 209:2183–2198.
   PubMed Web of Science ®Google Scholar
• Pekarsky Y, Zanesi N, Aqeilan RI, et al. Animal models for chronic lymphocytic leukemia. J Cell Biochem 2007;100:1109–1118.
   PubMed Web of Science ®Google Scholar
• Bäckman E, Bergh AC, Lagerdahl I, et al. Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro. Haematologica 2007;92:1495–1504.
   Google Scholar
• Nilsson J, Söderberg O, Nilsson K, et al. Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells. Blood 2000; 95:1420–1426.
   PubMed Web of Science ®Google Scholar
• Nilsson K. The control of growth and differentiation in chronic lymphocytic leukemia (B-CLL) cells. In: Cheson B, editor. Chronic lymphoytic leukemia Scientific advances and clinical developments. New York: Marcel Dekker; 1992. pp. 33–61.
   Google Scholar
• Söderberg A, Hossain A, Rosén A. A protein-disulfide isomerase/thioredoxin-1 complex is physically attached to exofacial membrane TNF-receptors: overexpression in chronic lymphocytic leukemia cells. Antioxid Redox Signal 2013;18:363–375.
   PubMed Web of Science ®Google Scholar
• Ghia P, Chiorazzi N, Stamatopoulos K. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J Intern Med 2008;264:549–562.
   PubMed Web of Science ®Google Scholar
• Hwang KK, Chen X, Kozink DM, et al. Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells. Blood 2012;119:e35–e44.
   Google Scholar
• Rosén A, Gergely P, Jondal M, et al. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature 1977;267:52–54.
   PubMed Web of Science ®Google Scholar
• Steinitz M, Klein G, Koskimies S, et al. EB virus-induced B lymphocyte cell lines producing specific antibody. Nature 1977;269: 420–422.
   PubMed Web of Science ®Google Scholar
• Rosén A, Persson K, Klein G. Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells. J Immunol 1983;130:2899–2902.
   PubMed Web of Science ®Google Scholar
• Maeda A, Bandobashi K, Nagy N, et al. Epstein-Barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins. J Hum Virol 2001;4:227–237.
   PubMedGoogle Scholar
• Wendel-Hansen V, Sällström J, De Campos-Lima PO, et al. Epstein-Barr virus (EBV) can immortalize B-CLL cells activated by cytokines. Leukemia 1994;8:476–484.
   PubMed Web of Science ®Google Scholar
• Klein E, Nagy N. Restricted expression of EBV encoded proteins in in vitro infected CLL cells. Semin Cancer Biol 2010;20: 410–415.
   Google Scholar
• Caligaris-Cappio F, Bergui L, Rege-Cambrin G, et al. Phenotypic, cytogenetic and molecular characterization of a new B-chronic lymphocytic leukaemia (B-CLL) cell line. Leuk Res 1987;11:579–588.
   PubMed Web of Science ®Google Scholar
• Fialkow PJ, Najfeld V, Reddy AL, et al. Chronic lymphocytic leukaemia: clonal origin in a committed B-lymphocyte progenitor. Lancet 1978;2:444–446.
   PubMed Web of Science ®Google Scholar
• Karande A, Fialkow PJ, Nilsson K, et al. Establishment of a lymphoid cell line from leukemic cells of a patient with chronic lymphocytic leukemia. Int J Cancer 1980;26:551–556.
   Google Scholar
• Lewin N, Åman P, Mellstedt H, et al. Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic lymphocytic leukemia (CLL) cells into permanent lines. Int J Cancer 1988;41:892–895.
   PubMed Web of Science ®Google Scholar
• Saltman D, Bansal NS, Ross FM, et al. Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; evidence of leukemic origin by immunoglobulin gene rearrangement. Leuk Res 1990;14:381–387.
   PubMed Web of Science ®Google Scholar
• Lanemo Myhrinder A, Hellqvist E, Sidorova E, et al. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood 2008;111:3838–3848.
   PubMed Web of Science ®Google Scholar
• Murray F, Darzentas N, Hadzidimitriou A, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008;111:1524–1533.
   PubMed Web of Science ®Google Scholar
• Buhl AM, Jurlander J, Geisler CH, et al. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia. Eur J Haematol 2006;76:455–464.
   PubMed Web of Science ®Google Scholar
• Mikaelsson E, Danesh-Manesh AH, Luppert A, et al. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Blood 2005;105:4828–4835.
   PubMed Web of Science ®Google Scholar
• Herling M, Patel KA, Teitell MA, et al. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. Blood 2008;111:328–337.
   PubMed Web of Science ®Google Scholar
• Shankey TV, Forman M, Scibelli P. Optimized whole-blood assay for measurement of ZAP-70 protein expression. Curr Protoc Cytom 2007;Chapter 9:Unit9.22.
   PubMedGoogle Scholar
• Herling M, Patel KA, Weit N, et al. High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia. Blood 2009;114:4675–4686.
   PubMed Web of Science ®Google Scholar
• Drexler HG. The leukemia-lymphoma cell line facts book. San Diego, CA: Academic Press; 2001.
   Google Scholar
• Stacchini A, Aragno M, Vallario A, et al. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res 1999;23:127–136.
   PubMed Web of Science ®Google Scholar
• Cao F, Amato D, Wang C. Concurrent chronic lymphocytic leukemia and prolymphocytic leukemia derived from two separate B-cell clones. Am J Hematol 2011;86:782.
   PubMed Web of Science ®Google Scholar
• Najfeld V, Fialkow PJ, Karande A, et al. Chromosome analyses of lymphoid cell lines derived from patients with chronic lymphocytic leukemia. Int J Cancer 1980;26:543–549.
   Google Scholar
• Josefsson P, Geisler CH, Leffers H, et al. CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia. Blood 2007;109:4973–4979.
   PubMed Web of Science ®Google Scholar
• Binder M, Lechenne B, Ummanni R, et al. Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells. PLoS One 2010;5:e15992.
   PubMed Web of Science ®Google Scholar
• Rosén A, Murray F, Evaldsson C, et al. Antigens in chronic lymphocytic leukemia–implications for cell origin and leukemogenesis. Semin Cancer Biol 2010;20:400–409.
   PubMed Web of Science ®Google Scholar
• Herling M, Patel KA, Khalili J, et al. TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia 2006;20: 280–285.
   PubMed Web of Science ®Google Scholar
• Lee S, Sakakibara S, Maruo S, et al. Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1. J Virol 2009;83:12368–12377.
   PubMed Web of Science ®Google Scholar
• Anastasiadou E, Boccellato F, Vincenti S, et al. Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b. Oncogene 2010;29:1316–1328.
   PubMed Web of Science ®Google Scholar
• Siemer D, Kurth J, Lang S, et al. EBV transformation overrides gene expression patterns of B cell differentiation stages. Mol Immunol 2008;45:3133–3141.
   PubMed Web of Science ®Google Scholar
• Caliskan M, Cusanovich DA, Ober C, et al. The effects of EBV transformation on gene expression levels and methylation profiles. Hum Mol Genet 2011;20:1643–1652.
   PubMed Web of Science ®Google Scholar